🇺🇸 FDA
Patent

US 7094597

Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7094597 (Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis) held by The Regents of the University of California expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K39/00, A61K39/0008, A61K39/40